Dual-energy Computed Tomography for Predicting Histological Grading and Survival in Patients with Pancreatic Ductal Adenocarcinoma

Overview

Journal Eur Radiol

Specialty Radiology

Date 2024 Oct 16

PMID 39414655

Authors

Weiyue Chen

Guihan Lin

Xia Li

Ye Feng

Weibo Mao

Chunli Kong

Yumin Hu

Yang Gao

Weibin Yang

Minjiang Chen

Zhihan Yan

Shuiwei Xia

Chenying Lu

Min Xu

Jiansong Ji

Affiliations

Soon will be listed here.

Abstract

Objectives: We evaluated the value of dual-energy computed tomography (DECT) parameters derived from pancreatic ductal adenocarcinoma (PDAC) to discriminate between high- and low-grade tumors and predict overall survival (OS) in patients.

Methods: Data were retrospectively collected from 169 consecutive patients with pathologically confirmed PDAC who underwent third-generation dual-source DECT enhanced dual-phase scanning before surgery between January 2017 and March 2023. Patients with prior treatments, other malignancies, small tumors, or poor-quality scans were excluded. Two radiologists evaluated three clinical and seven radiological features and measured sixteen DECT-derived parameters. Univariate and multivariate analyses were applied to select independent predictors. A prediction model and a corresponding nomogram were developed, and the area under the curve (AUC), calibration, and clinical applicability were assessed. The correlations between factors and OS were evaluated using Kaplan-Meier survival and Cox regression analyses.

Results: One hundred sixty-nine patients were randomly divided into training (n = 118) and validation (n = 51) cohorts, among which 43 (36.4%) and 19 (37.3%) had high-grade PDAC confirmed by pathology, respectively. The vascular invasion, normalized iodine concentration in the venous phase, and effective atomic number in the venous phase were independent predictors for histological grading. A nomogram was constructed to predict the risk of high-grade tumors in PDAC, with AUCs of 0.887 and 0.844 in the training and validation cohorts, respectively. The nomogram exhibited good calibration and was more beneficial than a single parameter in both cohorts. Pathological- and nomoscore-predicted high-grade PDACs were associated with poor OS (all p < 0.05).

Conclusions: The nomogram, which combines DECT parameters and radiological features, can predict the histological grade and OS in patients with PDAC before surgery.

Key Points: Question Preoperative determination of histological grade in PDAC is crucial for guiding treatment, yet current methods are invasive and limited. Findings A DECT-based nomogram combining vascular invasion, normalized iodine concentration, and effective atomic number accurately predicts histological grade and OS in PDAC patients. Clinical relevance The DECT-based nomogram is a reliable, non-invasive tool for predicting histological grade and OS in PDAC. It provides essential information to guide personalized treatment strategies, potentially improving patient management and outcomes.

References

Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

Kolbeinsson H, Chandana S, Wright G, Chung M . Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. J Invest Surg. 2022; 36(1):2129884. DOI: 10.1080/08941939.2022.2129884. View

Hu J, Zhao C, Chen W, Liu Q, Li Q, Lin Y . Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021; 27(27):4298-4321. PMC: 8316912. DOI: 10.3748/wjg.v27.i27.4298. View

Dunet V, Halkic N, Sempoux C, Demartines N, Montemurro M, Prior J . Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma. Eur Radiol. 2020; 31(2):992-1001. PMC: 7813698. DOI: 10.1007/s00330-020-07191-z. View

Macias N, Sayagues J, Esteban C, Iglesias M, Gonzalez L, Quinones-Sampedro J . Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy. J Clin Gastroenterol. 2017; 52(2):e11-e17. DOI: 10.1097/MCG.0000000000000793. View

Liu L, Xu H, He M, Wang W, Wang W, Wu C . A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging. Surgery. 2018; 163(6):1280-1294. DOI: 10.1016/j.surg.2018.01.017. View

Chang N, Cui L, Luo Y, Chang Z, Yu B, Liu Z . Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma. Quant Imaging Med Surg. 2020; 10(3):692-702. PMC: 7136722. DOI: 10.21037/qims.2020.02.21. View

Nurmi A, Mustonen H, Parviainen H, Peltola K, Haglund C, Seppanen H . Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer. Acta Oncol. 2017; 57(6):799-806. DOI: 10.1080/0284186X.2017.1415458. View

Javed A, Pulvirenti A, Razi S, Zheng J, Michelakos T, Sekigami Y . Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-institutional Study. Ann Surg. 2022; 277(6):e1284-e1290. PMC: 9364076. DOI: 10.1097/SLA.0000000000005390. View

10.

Ye J, Fang P, Peng Z, Huang X, Xie J, Yin X . A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors. Eur Radiol. 2023; 34(3):1994-2005. PMC: 10873440. DOI: 10.1007/s00330-023-10186-1. View

11.

Zhu H, Zhu H, Jiang L, Nie P, Hu J, Tang W . Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol. 2023; 34(1):90-102. PMC: 10791720. DOI: 10.1007/s00330-023-09957-7. View

12.

Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

13.

Coursey C, Nelson R, Boll D, Paulson E, Ho L, Neville A . Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging?. Radiographics. 2010; 30(4):1037-55. DOI: 10.1148/rg.304095175. View

14.

Mileto A, Marin D, Alfaro-Cordoba M, Ramirez-Giraldo J, Eusemann C, Scribano E . Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. Radiology. 2014; 273(3):813-20. DOI: 10.1148/radiol.14140171. View

15.

Liu X, OuYang D, Li H, Zhang R, Lv Y, Yang A . Papillary thyroid cancer: dual-energy spectral CT quantitative parameters for preoperative diagnosis of metastasis to the cervical lymph nodes. Radiology. 2014; 275(1):167-76. DOI: 10.1148/radiol.14140481. View

16.

Wu J, Lv Y, Wang N, Zhao Y, Zhang P, Liu Y . The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer. Eur Radiol. 2019; 29(7):3782-3790. DOI: 10.1007/s00330-019-06144-5. View

17.

Cao Y, Zhang G, Bao H, Ren J, Wang Z, Zhang J . Development of a dual-energy spectral computed tomography-based nomogram for the preoperative discrimination of histological grade in colorectal adenocarcinoma patients. J Gastrointest Oncol. 2021; 12(2):544-555. PMC: 8107588. DOI: 10.21037/jgo-20-368. View

18.

Chuang-Bo Y, Tai-Ping H, Hai-Feng D, Yong-Jun J, Xi-Rong Z, Guang-Ming M . Quantitative assessment of the degree of differentiation in colon cancer with dual-energy spectral CT. Abdom Radiol (NY). 2017; 42(11):2591-2596. DOI: 10.1007/s00261-017-1176-6. View

19.

Wen Y, Song Z, Li Q, Zhang D, Li X, Yu J . Development and validation of a model for predicting the expression of Ki-67 in pancreatic ductal adenocarcinoma with radiological features and dual-energy computed tomography quantitative parameters. Insights Imaging. 2024; 15(1):41. PMC: 10866831. DOI: 10.1186/s13244-024-01617-8. View

20.

Fujita N, Ushijima Y, Itoyama M, Okamoto D, Ishimatsu K, Wada N . Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. Eur J Radiol. 2023; 162:110756. DOI: 10.1016/j.ejrad.2023.110756. View